BUY Piramal Pharma — Anshul Jain, 27 May 2026

BUYPiramal Pharma Limited

Piramal Pharma share price target & all analyst calls

byAnshul Jain, Lakshmishree Investment and SecuritiesHorizon: 1–3 months27 May 2026via Business Today

Entry₹175.71Inferred

Target₹240

Total upside +36.59%

Stop lossNot given

At expiry₹211.2927 Aug 2026, 3:30 pm

Expired+20.25%

Follow Anshul Jain for new calls(18% target hit, 11 closed calls)Get alerts Watch PPLPHARMA for new buy/sell callsGet alerts See 2 active Short-term calls on PPLPHARMA See 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 27 Aug 2026

17 supporting8 neutral5 opposing

Supports the BUY call (17)

4 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·27 Aug · today

3 other SEBI-registered advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·26 Aug · yesterday

Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited

NewsGoogle News·24 Aug · 3d ago

Yapan Bio to become Piramal subsidiary following acquisition

NewsGoogle News·20 Aug · 1w ago

Piramal Pharma Limited has acquired an additional 40.67% stake in Yapan Bio Private Limited for approximately ₹76 crores, increasing its shareholding from 33.33% to 74.00%. Yapan has now become a subs

NSE · Acquisition·18 Aug · 1w ago

Neutral / worth noting (8)

Piramal Pharma emphasises sustainability in FY 2025-26 report

NewsGoogle News·24 Aug · 2d ago

Piramal Pharma Block Deal: Seller likely to offload 6% stake for around ₹1,750 crore

NewsCnbc-Tv18·13 Aug · 2w ago

Buy, Sell Or Hold: Mahindra & Mahindra, UltraTech Cement, Piramal Pharma, Groww And Swiggy — Ask Profit

NewsNdtv-Profit·30 Jul · 4w ago

Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·29 Jul · 4w ago

Weighs against the BUY call (5)

Piramal Pharma reports 22.6% drop in Scope 1 & 2 emissions for FY26

NewsGoogle News·24 Aug · 2d ago

Piramal Pharma block deal likely cancelled; stock falls 3%

NewsCnbc-Tv18·14 Aug · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Anshul Jain, Lakshmishree Investment and Securities

Every call and its outcome

BUY Piramal Pharma Limited — Anshul Jain, Lakshmishree Investment and Securities

AI Assessment

Other calls on Piramal Pharma

More from Anshul Jain, Lakshmishree Investment and Securities